Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Clinical practice. Gastroesophageal reflux disease. N Engl J Med (2008) 3.30

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2013) 2.96

A single progenitor population switches behavior to maintain and repair esophageal epithelium. Science (2012) 2.68

Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut (2006) 2.28

Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults. Surg Endosc (2012) 2.28

The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut (2007) 2.10

Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc (2013) 2.07

Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82

Gastro-oesophageal reflux disease. BMJ (2006) 1.81

Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol (2013) 1.80

Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study. PLoS Med (2015) 1.74

Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause? Can Fam Physician (2007) 1.61

Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring) (2013) 1.60

Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia. Gut (2009) 1.59

Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China. Ann Surg (2016) 1.57

Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy. Dig Dis Sci (2014) 1.54

The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci (2008) 1.49

Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol (2015) 1.47

Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt. Ann Surg (2007) 1.44

Antireflux surgery for dysplastic Barrett. World J Surg (2015) 1.40

Transient receptor potential vanilloid 4 (TRPV4)-dependent calcium influx and ATP release in mouse oesophageal keratinocytes. J Physiol (2011) 1.37

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol (2013) 1.35

Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32

Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol (2008) 1.31

Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25

Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract (2007) 1.24

Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci (2009) 1.21

Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci (2007) 1.20

NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20

Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol (2009) 1.18

Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg (2009) 1.18

A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol (2010) 1.16

Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am J Gastroenterol (2009) 1.14

Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol (2008) 1.09

Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther (2015) 1.08

Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05

Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS One (2013) 1.05

Risk factors of gastroesophageal reflux disease in Shiraz, southern Iran. World J Gastroenterol (2007) 1.03

Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol (2009) 1.03

Sleep, immunity and inflammation in gastrointestinal disorders. World J Gastroenterol (2013) 1.02

Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes (2009) 1.02

Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis. World J Gastroenterol (2015) 1.01

Prevalence and risk factors of gastroesophageal reflux disease in Qashqai migrating nomads, southern Iran. World J Gastroenterol (2009) 1.01

Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2010) 1.01

Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores. BMC Med (2012) 1.00

Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population. J Gastroenterol (2012) 1.00

Systematic review of the epidemiology of gastroesophageal reflux disease in Japan. J Gastroenterol (2011) 0.99

Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.99

New developments in extraesophageal reflux disease. Gastroenterol Hepatol (N Y) (2012) 0.98

Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome-the heart to gut connection! J Interv Card Electrophysiol (2013) 0.98

Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol (2013) 0.97

Videoendoscopy and histopathology of the esophagogastric junction in patients with gastroesophageal reflux disease. Wien Klin Wochenschr (2007) 0.97

Long-Term Results of Radiofrequency Energy Delivery for the Treatment of GERD: Results of a Prospective 48-Month Study. Diagn Ther Endosc (2011) 0.97

A cluster randomised controlled trial evaluating the effectiveness of eHealth-supported patient recruitment in primary care research: the TRANSFoRm study protocol. Implement Sci (2015) 0.97

Gastroesophageal reflux disease: Update on inflammation and symptom perception. World J Gastroenterol (2013) 0.97

Laparoscopic management of totally intra-thoracic stomach with chronic volvulus. World J Gastroenterol (2013) 0.96

p73 protein regulates DNA damage repair. FASEB J (2011) 0.96

Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.96

GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci (2014) 0.96

Cough in adult cystic fibrosis: diagnosis and response to fundoplication. Cough (2009) 0.96

Current trends in the management of gastroesophageal reflux disease: a review. ISRN Gastroenterol (2012) 0.95

Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J (2016) 0.95

Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.95

Association of sleep dysfunction and emotional status with gastroesophageal reflux disease in Korea. J Neurogastroenterol Motil (2013) 0.95

LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol (2013) 0.95

Impact of body mass index and gender on quality of life in patients with gastroesophageal reflux disease. World J Gastroenterol (2012) 0.94

A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD). Ther Clin Risk Manag (2007) 0.94

Combined Dual Channel Impedance/pH-metry in Patients With Suspected Laryngopharyngeal Reflux. J Neurogastroenterol Motil (2010) 0.94

Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2009) 0.94

Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians. Int J Clin Pract (2007) 0.94

Management of complications after laparoscopic Nissen's fundoplication: a surgeon's perspective. Ann Surg Innov Res (2009) 0.93

Aerophagia and gastroesophageal reflux disease in patients using continuous positive airway pressure: a preliminary observation. J Clin Sleep Med (2008) 0.93

New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil (2013) 0.93

Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease. J Neurogastroenterol Motil (2015) 0.92

Prospective Acid Reflux Study of Iran (PARSI): methodology and study design. BMC Gastroenterol (2007) 0.92

Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol (2008) 0.92

Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf) (2014) 0.91

Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol (2011) 0.91

The value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with low prevalence of gastroesophageal reflux disease. J Neurogastroenterol Motil (2011) 0.91

Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors. World J Gastrointest Surg (2016) 0.91

Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls. Neurogastroenterol Motil (2012) 0.91

The prevalence of laryngopharyngeal reflux in the English population. Eur Arch Otorhinolaryngol (2012) 0.90

Relevance of ultrastructural alterations of intercellular junction morphology in inflamed human esophagus. J Neurogastroenterol Motil (2013) 0.90

Role of digital chromoendoscopy in detecting minimal change esophageal reflux disease. World J Gastrointest Endosc (2010) 0.90

Post-fundoplication contrast studies: is there room for improvement? Br J Radiol (2011) 0.90

Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa. Am J Physiol Gastrointest Liver Physiol (2015) 0.90

Evidence-based appraisal in laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. World J Gastroenterol (2010) 0.90

Incidence and risk factors of recurrent acute lung injury. Crit Care Med (2011) 0.89

Evaluation and management of dyspepsia. Therap Adv Gastroenterol (2010) 0.89

Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials. Open Med (2007) 0.89

Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria. Dig Dis Sci (2014) 0.89

Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology (2008) 0.88

Gastroesophageal reflux disease and morbid obesity: is there a relation? World J Surg (2009) 0.88

Epidemiology of peptic ulcer disease: endoscopic results of a systematic investigation in iran. Middle East J Dig Dis (2012) 0.88

Does the cost of robotic cholecystectomy translate to a financial burden? Surg Endosc (2014) 0.88

Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol (2015) 0.88

The Prevalence of Gastroesophageal Reflux Disease (GERD) in the Islamic Republic of Iran: A Systematic Review. Middle East J Dig Dis (2012) 0.88

Non-pharmacological intervention for gastro-oesophageal reflux disease in primary care. Br J Gen Pract (2010) 0.88

Sonographic measurement of abdominal esophageal length as a diagnostic tool in gastroesophageal reflux disease in infants. Saudi J Gastroenterol (2011) 0.88

Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease. Am J Med Sci (2015) 0.88

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis (1976) 3.71

An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut (1999) 3.45

Gastroesophageal reflux among different racial groups in the United States. Gastroenterology (2004) 2.87

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion (1992) 2.40

Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35

Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther (2003) 2.30

Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol (1998) 2.24

Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther (2004) 2.13

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med (1995) 1.97

Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut (2003) 1.85

Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84

Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology (2004) 1.82

Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology (2002) 1.76

Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther (2002) 1.71

Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl (1999) 1.69

Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology (1997) 1.66

The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther (2000) 1.64

Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther (2004) 1.61

Heartburn and globus in apparently healthy people. Can Med Assoc J (1982) 1.58

Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut (1998) 1.57

Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology (2001) 1.50

Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med (2000) 1.49

Risk factors for Barrett's esophagus: a case-control study. Int J Cancer (2002) 1.49

Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (1997) 1.46

Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol (1999) 1.43

Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl (1999) 1.35

Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J (2000) 1.34

Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol (1991) 1.27

Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med (1999) 1.26

The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol (1991) 1.26

Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol (2002) 1.25

Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer (2000) 1.23

Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res (2001) 1.22

Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization. World J Gastroenterol (2004) 1.22

Associations between different forms of gastro-oesophageal reflux disease. Gut (1997) 1.21

Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol (2002) 1.18

Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther (2001) 1.17

Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol (2003) 1.17

Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J Gastroenterol (2003) 1.15

Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci (1999) 1.14

Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol (2003) 1.12

Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice. Br J Clin Pract (1996) 1.10

Gastro-esophageal reflux disease in northwestern Tabriz, Iran. Indian J Gastroenterol (2003) 1.07

Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey. J Gastroenterol Hepatol (2004) 1.00

Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study. Aliment Pharmacol Ther (2004) 0.98

Racial differences in the prevalence of heartburn. Aliment Pharmacol Ther (2004) 0.92

Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study. Ann Epidemiol (2001) 0.91

Gastroesophageal reflux and quality of life. Patient's knowledge, attitudes and perceptions. Aust Fam Physician (1999) 0.86

Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80

Cell-surface glycosaminoglycans. Annu Rev Biochem (1984) 3.68

Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J (1986) 3.54

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90

Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut (2008) 2.79

The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther (2007) 2.59

Beta 1 integrin-dependent and -independent polymerization of fibronectin. J Cell Biol (1996) 2.44

Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health (2009) 2.44

The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther (2005) 2.40

Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. J Cell Biol (1995) 2.39

Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20

Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19

Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun (2001) 2.18

The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut (2007) 2.10

Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med (2007) 1.97

Epigenetic modulation at birth - altered DNA-methylation in white blood cells after Caesarean section. Acta Paediatr (2009) 1.95

Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90

Characterization of protease-resistant fragments of laminin mediating attachment and spreading of rat hepatocytes. J Biol Chem (1983) 1.87

Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther (2009) 1.83

Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother (2001) 1.76

Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol (1988) 1.73

Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro. Proc Natl Acad Sci U S A (1988) 1.68

Accidental lesions of the common bile duct at cholecystectomy. II. Results of treatment. Ann Surg (1985) 1.67

The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther (2006) 1.65

A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61

Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther (2004) 1.61

Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59

In vitro biosynthesis of cold insoluble globulin (fibronectin) by mouse peritoneal macrophages. FEBS Lett (1979) 1.59

Substrate adhesion of rat hepatocytes: on the mechanism of attachment to fibronectin. J Cell Biol (1984) 1.57

Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol (2001) 1.56

Adhesion of glycosaminoglycan-deficient chinese hamster ovary cell mutants to fibronectin substrata. J Cell Biol (1988) 1.55

Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol (2009) 1.55

Vertical InAs nanowire wrap gate transistors with f(t) > 7 GHz and f(max) > 20 GHz. Nano Lett (2010) 1.53

Substrate adhesion of rat hepatocytes: a comparison of laminin and fibronectin as attachment proteins. J Cell Biol (1981) 1.52

Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol (2000) 1.52

Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2010) 1.49

A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun (2008) 1.47

The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry (2011) 1.46

The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther (2013) 1.45

Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther (2012) 1.45

Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther (2012) 1.40

Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther (2007) 1.39

Might free arterial grafts fail due to spasm? Ann Thorac Surg (1991) 1.39

Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther (2005) 1.38

Determination of the border between the transmembrane and cytoplasmic domains of human integrin subunits. J Biol Chem (1999) 1.37

Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines. Biotechnology (N Y) (1993) 1.35

Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol (2000) 1.32

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand (1992) 1.32

The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol (2001) 1.32

Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther (2008) 1.30

Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics. Cancer (1974) 1.29

Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia (2008) 1.28

Identification of cases of myocardial infarction: hospital discharge data and mortality data compared to myocardial infarction community registers. Int J Epidemiol (1991) 1.28

Heparin enhances the rate of binding of fibronectin to collagen. Biochem J (1980) 1.27

CHD in Sweden: mortality, incidence and risk factors over 20 years in Gothenburg. Int J Epidemiol (1989) 1.26

Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril (1992) 1.26

Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther (2007) 1.25

Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril (1994) 1.22

HER2/neu amplification and comedo type breast carcinoma. Lancet (1989) 1.22

Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect (2004) 1.20

Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med (2004) 1.15

Comparison of fibronectin receptors from rat hepatocytes and fibroblasts. J Biol Chem (1987) 1.15

The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther (2014) 1.14

Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int (1978) 1.14

Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors. Hepatology (1999) 1.14

A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. Dev Biol (1989) 1.13

Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin beta1A. Requirement for threonines 788-789 in receptor activation. J Cell Sci (1998) 1.13

The cytoplasmic tyrosines of integrin subunit beta1 are involved in focal adhesion kinase activation. Mol Cell Biol (2000) 1.13

Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther (2008) 1.12

Fibronectin fibril formation involves cell interactions with two fibronectin domains. Exp Cell Res (1988) 1.11

Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med (2008) 1.10

Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med (2004) 1.09

Assembly of laminin polymers is dependent on beta1-integrins. Exp Cell Res (2001) 1.08

Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther (2007) 1.08

Risk factors for cardiovascular disease during the period 1985-1995 in Göteborg, Sweden. The GOT-MONICA Project. J Intern Med (1997) 1.07

Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther (2010) 1.07

Prognostic importance of cholesterol levels after myocardial infarction. Prev Med (1984) 1.07

Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther (2008) 1.06

Effective dose range of enalapril in mild to moderate essential hypertension. Br J Clin Pharmacol (1985) 1.05

Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group. Acta Oncol (2000) 1.04

Seven novel macrocyclic polypeptides from Viola arvensis. J Nat Prod (1999) 1.04

Myocardial infarction in women. Epidemiol Rev (1983) 1.04

Attachment of rat hepatocytes to collagen and fibronectin; a study using antibodies directed against cell surface components. Biochem Biophys Res Commun (1979) 1.03

Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making. Dis Esophagus (2013) 1.03

Long-term prognosis after myocardial infarction in men with diabetes. Diabetes (1985) 1.02

Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer (2013) 1.02

Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50. J Intern Med (2009) 1.02

Structure and interactions of proteoglycans in the extracellular matrix produced by cultured human fibroblasts. Biochem J (1985) 1.02

Sex differences in preinfarction characteristics and longterm survival among patients with myocardial infarction. Am J Epidemiol (1984) 1.02

Demonstration of high affinity fibronectin receptors on rat hepatocytes in suspension. J Biol Chem (1985) 1.01

Studies in vivo and in vitro on the uptake and degradation of soluble collagen alpha 1(I) chains in rat liver endothelial and Kupffer cells. Biochem J (1985) 1.00

Endometrial carcinoma; ovarian dysfunction--a risk factor in young women. Eur J Obstet Gynecol Reprod Biol (1991) 1.00

Integrin-type fibronectin receptors of rat arterial smooth muscle cells: isolation, partial characterization and role in cytoskeletal organization and control of differentiated properties. Differentiation (1989) 1.00